Insider Transactions in Q4 2025 at Talaris Therapeutics, Inc. (TALS)
Insider Transaction List (Q4 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 28
2025
|
Sandeep Chidambar Kulkarni CEO |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Indirect |
7,000
-100.0%
|
-
|
|
Oct 28
2025
|
Sandeep Chidambar Kulkarni CEO |
SELL
Sale (or disposition) back to the issuer
|
Direct |
30,387
-100.0%
|
-
|
|
Oct 28
2025
|
Sandeep Chidambar Kulkarni CEO |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
724,664
-95.98%
|
-
|
|
Oct 28
2025
|
Ryan F. Robinson CFO |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
14,366
-100.0%
|
-
|
|
Oct 28
2025
|
W Bradford Middlekauff CBO, GC and Secretary |
SELL
Sale (or disposition) back to the issuer
|
Direct |
8,213
-100.0%
|
-
|
|
Oct 28
2025
|
W Bradford Middlekauff CBO, GC and Secretary |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
60,988
-88.13%
|
-
|
|
Oct 28
2025
|
Susan Dana Jones Chief Technology Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
3,152
-100.0%
|
-
|
|
Oct 28
2025
|
Susan Dana Jones Chief Technology Officer |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
19,782
-86.26%
|
-
|
|
Oct 28
2025
|
Kevin Bruce Johnson Chief Regulatory Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
11,046
-100.0%
|
-
|
|
Oct 28
2025
|
Kevin Bruce Johnson Chief Regulatory Officer |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
40,538
-78.59%
|
-
|
|
Oct 28
2025
|
Caley Castelein |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Indirect |
431,939
-100.0%
|
-
|
|
Oct 28
2025
|
Caley Castelein |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
515,997
-100.0%
|
-
|
|
Oct 28
2025
|
Aaron Kantoff |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
88,281
-100.0%
|
-
|
|
Oct 28
2025
|
Mark Mcdade |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Indirect |
741,691
-100.0%
|
-
|
|
Oct 28
2025
|
Mark Mcdade |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
518
-100.0%
|
-
|
|
Oct 28
2025
|
Sapna Srivastava |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
518
-100.0%
|
-
|
|
Oct 28
2025
|
Parvinder Thiara |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
83,782
-100.0%
|
-
|
|
Oct 24
2025
|
Aaron Kantoff |
SELL
Bona fide gift
|
Direct |
5,000
-5.36%
|
-
|
|
Oct 22
2025
|
Sandeep Chidambar Kulkarni CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
25,316
+3.24%
|
$177,212
$7.9 P/Share
|
|
Oct 22
2025
|
Ryan F. Robinson CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
14,366
+50.0%
|
$186,758
$13.92 P/Share
|
|
Oct 15
2025
|
Caley Castelein |
SELL
Bona fide gift
|
Direct |
522
-0.1%
|
-
|
|
Oct 15
2025
|
Kevin Bruce Johnson Chief Regulatory Officer |
SELL
Bona fide gift
|
Direct |
6,250
-10.81%
|
-
|